Organization

Four subsidiaries of Cellectis were created between 2008 and 2010. Their aim is to fully develop the applications of our technology within their given market sectors. The parent company centralizes the financial management of the group, the intellectual property, the legal department and other support functions, as well as the research and development around Genome engineering technologies. The “DNA scissors" platform production will remain the strategic center of the company as a whole and will remain the driving force of the group activity.